Answers are grounded in this paper and cite their sources.
Patients with NASH cirrhosis are not disadvantaged by higher waitlist removal or lower transplantation rates.
No takes yet. Share an insight, caveat, or question.
Thuluvath et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: